- Price
- $74.48
- Day
- +6.61%
- Mkt Cap
- $2.54B
- 52W Range
- $31.84 – $82.11
- Volume
- 549.3K
- Beta
- 0.65
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Arrowstreet Capital Limited Partnership lowered its holdings in The Andersons, Inc. (NASDAQ: ANDE) by 67.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,999 shares of the basic materials company's stock after selling 92,421 shares during the quarter. Arrowstreet Capital Limited Partnership
Read full article
The Andersons, Inc. (ANDE) Q2 2026 Earnings Call Transcript
Read full article
Andersons NASDAQ: ANDE reported sharply higher second-quarter earnings as record performance in its Renewables segment and improved fertilizer operations lifted results during what management described as an unpredictable first half of 2026.
Read full article
MAUMEE, Ohio, Aug. 3, 2026 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces financial results for the second quarter ended June 30, 2026. Financial Highlights: Second quarter net income attributable to The Andersons of $57 million or $1.65 per diluted share and adjusted net income attributable of $74 million, or $2.15 per diluted share Adjusted EBITDA of $140 million Renewables reports record second quarter pretax income of $65 million and adjusted pretax income of $88 million on record production, strong merchandising, and 45Z tax credits Agribusiness pretax and adjusted pretax income attributable to The Andersons of $20 million on solid fertilizer performance "Our second quarter results reflect continued outstanding performance in Renewables and year-over-year improvement in Agribusiness," said President and CEO Bill Krueger.
Read full article
The Andersons Inc. is rated Buy, trading at 14.18x forward P/E versus a 15.23x five-year average and sector median of 15.29x. Valuation asymmetry stems from the $425M ethanol JV buyout, which increased debt but not EBITDA, distorting EV/EBITDA metrics. FY2027 consensus EPS of $6.03 underpins a base-case price target near $92, with estimate revisions trending upward and risk skewed to the upside.
Read full article